Back
Materialise NV Vs. Aligos Therapeutics Industry Stock Comparison
Buy
54
MTLS
Materialise NV
Last Price:
$6.19
Seasonality Move:
1.35%
Sell
46
ALGS
Aligos Therapeutics
Last Price:
$9.27
Seasonality Move:
-24.68%
Buy
54
Materialise NV (MTLS)
is a Buy
Is Materialise NV a Buy, Sell or Hold?
-
The current Materialise NV [MTLS] share price is $6.06. The Score for MTLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
MTLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $9.12. The Score for ALGS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTLS Stock Price Chart
What is Materialise NV's stock price today?
-
The Materialise NV share price today is $6.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $9.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.61 | Buy |
Relative Strength Index (14 RSI): | 61.42 | Buy |
Chaikin Money Flow: | 35282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.51 - 5.89) | Buy |
Bollinger Bands (100): | (4.82 - 5.68) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 61.29 | Buy |
Chaikin Money Flow: | 66275 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.42 - 8.74) | Buy |
Bollinger Bands (100): | (4.89 - 10.49) | Buy |
MTLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.9 | Buy |
20-day SMA: | 5.75 | Buy |
50-day SMA: | 5.55 | Buy |
200-day SMA: | 6.18 | Sell |
8-day EMA: | 5.56 | Buy |
20-day EMA: | 3.94 | Buy |
50-day EMA: | 2.1 | Buy |
200-day EMA: | 0.61 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.77 | Buy |
20-day SMA: | 8.17 | Buy |
50-day SMA: | 7.11 | Buy |
200-day SMA: | 15.2 | Sell |
8-day EMA: | 8.77 | Buy |
20-day EMA: | 8.28 | Buy |
50-day EMA: | 7.92 | Buy |
200-day EMA: | 12.62 | Sell |
Materialise NV Earnings Growth & MTLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.08 per share, and an increase next year of $0.15 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Materialise NV Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |